Frequency Therapeutics is a clinical-stage biotechnology company focused on developing therapeutics to activate a person's innate regenerative potential to restore function. Co. develops FX-322 to treat an underlying cause of sensorineural hearing loss, which is the loss of hair cells. Co.'s proprietary approach, Progenitor Cell Activation, uses small molecules to activate progenitor cells within the body to create functional tissue. These progenitor cells, which are closely related to stem cells, are already resident in the targeted location in the body and programmed to develop and differentiate into specific cell types within an organ. We show 17 historical shares outstanding datapoints in our FREQ shares outstanding history coverage, used to compute FREQ market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing FREQ market cap history over the course of time is important for investors
interested in comparing FREQ's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of FREQ versus a peer is one thing; comparing
FREQ market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like FREQ can fluctuate over the course of history.
With this page we aim to empower investors researching FREQ by allowing them to research the FREQ market cap history. |
Free FREQ Email Alerts:
Video: The Importance of Market Cap
